Marco Ferroni, PhD

Bio:

Marco Ferroni, PhD is a biomedical engineer and the co-founder and Chief Executive Officer of MgShell, where he leads the company’s strategic direction, intellectual property, fundraising, and corporate development. He holds a PhD in Bioengineering from Politecnico di Milano, where his research focused on ocular drug delivery technologies. Marco has over 10 years of experience spanning scientific research, advanced drug delivery systems, and deep-tech entrepreneurship, with a strong focus on controlled release and intraocular therapeutic delivery. He has authored 16 scientific publications, co-invented 11 patents, and has successfully secured €2.5 million in non-dilutive and equity funding. Starting from his own academic research, Marco co-founded MgShell and has led its evolution from a university spin-off into a venture-backed start-up developing a proprietary bioresorbable drug-delivery platform for retinal diseases. His expertise includes sustained-release technologies, intraocular therapeutics, biodegradable biomaterials, and the translation of advanced drug delivery systems from concept toward clinical application passing through preclinical development. Passionate about innovation and technology transfer, he also mentors entrepreneurship and innovation programs at several national start-up incubators and accelerators, supporting the next generation of science-based entrepreneurs.